NASDAQ:AEMD - Aethlon Medical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$1.00 +0.01 (+1.01 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$1.00
Today's Range$0.9692 - $1.0150
52-Week Range$0.82 - $1.74
Volume11,416 shs
Average Volume82,664 shs
Market Capitalization$18.96 million
P/E Ratio-2.17
Dividend YieldN/A
Beta0.93
Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals. It is also involved in the development of exosomal biomarkers to diagnose and monitor life-threatening disease conditions, such as cancer and neurological disorders; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection. The company was founded in 1991 and is based in San Diego, California.

Receive AEMD News and Ratings via Email

Sign-up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AEMD
CUSIPN/A
Phone858-459-7800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$150,000.00
Book Value$0.36 per share

Profitability

Net Income$-5,670,000.00

Miscellaneous

EmployeesN/A
Market Cap$18.96 million
Next Earnings Date6/14/2019 (Estimated)
OptionableNot Optionable

Aethlon Medical (NASDAQ:AEMD) Frequently Asked Questions

What is Aethlon Medical's stock symbol?

Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD."

How were Aethlon Medical's earnings last quarter?

Aethlon Medical, Inc. (NASDAQ:AEMD) issued its earnings results on Monday, February, 11th. The medical equipment provider reported ($0.11) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.07) by $0.04. View Aethlon Medical's Earnings History.

When is Aethlon Medical's next earnings date?

Aethlon Medical is scheduled to release their next quarterly earnings announcement on Friday, June 14th 2019. View Earnings Estimates for Aethlon Medical.

What price target have analysts set for AEMD?

1 analysts have issued twelve-month price targets for Aethlon Medical's stock. Their predictions range from $3.00 to $3.00. On average, they expect Aethlon Medical's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 200.0% from the stock's current price. View Analyst Price Targets for Aethlon Medical.

What is the consensus analysts' recommendation for Aethlon Medical?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aethlon Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Aethlon Medical.

Has Aethlon Medical been receiving favorable news coverage?

News stories about AEMD stock have trended somewhat positive on Saturday, InfoTrie reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Aethlon Medical earned a news impact score of 0.9 on InfoTrie's scale. They also assigned headlines about the medical equipment provider a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an impact on the company's share price in the next few days.

Who are some of Aethlon Medical's key competitors?

What other stocks do shareholders of Aethlon Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include AT&T (T), NewLink Genetics (NLNK), Novavax (NVAX), Ur-Energy (URG), Allena Pharmaceuticals (ALNA), Agile Therapeutics (AGRX), Cytosorbents (CTSO), Rigel Pharmaceuticals (RIGL), Celldex Therapeutics (CLDX) and Ampliphi Biosciences (APHB).

Who are Aethlon Medical's key executives?

Aethlon Medical's management team includes the folowing people:
  • Mr. James B. Frakes, CFO & Sr. VP of Fin. (Age 62)
  • Mr. James A. Joyce, Consultant (Age 57)
  • Dr. Timothy C. Rodell, Interim CEO & Director (Age 68)
  • Mr. Sunil Sawhney, Head of Clinical Studies
  • Dr. Richard H. Tullis, Consultant (Age 74)

Who are Aethlon Medical's major shareholders?

Aethlon Medical's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Bank of New York Mellon Corp (0.17%).

Which major investors are buying Aethlon Medical stock?

AEMD stock was purchased by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp.

How do I buy shares of Aethlon Medical?

Shares of AEMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aethlon Medical's stock price today?

One share of AEMD stock can currently be purchased for approximately $1.00.

How big of a company is Aethlon Medical?

Aethlon Medical has a market capitalization of $18.96 million and generates $150,000.00 in revenue each year. The medical equipment provider earns $-5,670,000.00 in net income (profit) each year or ($0.46) on an earnings per share basis.

What is Aethlon Medical's official website?

The official website for Aethlon Medical is http://www.aethlonmedical.com.

How can I contact Aethlon Medical?

Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The medical equipment provider can be reached via phone at 858-459-7800 or via email at [email protected]


MarketBeat Community Rating for Aethlon Medical (NASDAQ AEMD)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  147 (Vote Outperform)
Underperform Votes:  117 (Vote Underperform)
Total Votes:  264
MarketBeat's community ratings are surveys of what our community members think about Aethlon Medical and other stocks. Vote "Outperform" if you believe AEMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AEMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel